WallStreetZenWallStreetZen

NASDAQ: MDGL
Madrigal Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for MDGL

Based on 7 analysts offering 12 month price targets for Madrigal Pharmaceuticals Inc.
Min Forecast
$225.00-13.44%
Avg Forecast
$332.57+27.94%
Max Forecast
$390.00+50.03%

Should I buy or sell MDGL stock?

Based on 7 analysts offering ratings for Madrigal Pharmaceuticals Inc.
Strong Buy
Strong Buy
3 analysts 42.86%
Buy
4 analysts 57.14%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MDGL stock forecasts and price targets.

MDGL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Oppenheimer
Top 2%
99
BuyMaintains$350.00+34.65%2023-05-16
Canaccord Genuity
Top 24%
77
Strong BuyReiterates$336.00+29.26%2023-05-10
JMP Securities
Top 8%
93
BuyMaintains$390.00+50.03%2023-01-05
UBS
Top 14%
87
Strong BuyMaintains$337.00+29.65%2022-12-21
HC Wainwright & Co.
Top 9%
92
BuyMaintains$225.00-13.44%2022-12-20
Goldman Sachs
Bottom 12%
12
Strong BuyMaintains$375.00+44.26%2022-12-20
SVB Leerink
Top 25%
76
BuyMaintains$315.00+21.18%2022-12-20

1 of 1

Forecast return on equity

Is MDGL forecast to generate an efficient return?
Company
N/A
Industry
0.1%
Market
71.96%

Forecast return on assets

Is MDGL forecast to generate an efficient return on assets?
Company
N/A
Industry
0.12%

MDGL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MDGL$259.94$332.57+27.94%Strong Buy
PCVX$50.73$62.75+23.69%Strong Buy
ALKS$29.51$33.67+14.09%Buy
HALO$33.57$55.00+63.84%Strong Buy
CRSP$65.00$69.40+6.78%Buy

Madrigal Pharmaceuticals Stock Forecast FAQ

Is Madrigal Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: MDGL) stock is to Strong Buy MDGL stock.

Out of 7 analysts, 3 (42.86%) are recommending MDGL as a Strong Buy, 4 (57.14%) are recommending MDGL as a Buy, 0 (0%) are recommending MDGL as a Hold, 0 (0%) are recommending MDGL as a Sell, and 0 (0%) are recommending MDGL as a Strong Sell.

If you're new to stock investing, here's how to buy Madrigal Pharmaceuticals stock.

What is MDGL's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: MDGL) forecast ROE is N/A, which is considered weak.

What is MDGL's Price Target?

According to 7 Wall Street analysts that have issued a 1 year MDGL price target, the average MDGL price target is $332.57, with the highest MDGL stock price forecast at $390.00 and the lowest MDGL stock price forecast at $225.00.

On average, Wall Street analysts predict that Madrigal Pharmaceuticals's share price could reach $332.57 by May 16, 2024. The average Madrigal Pharmaceuticals stock price prediction forecasts a potential upside of 27.94% from the current MDGL share price of $259.94.

What is MDGL's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: MDGL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.